References
- Goronzy J. J., Weyand C. M. Rheumatoid arthritis. Immunol Rev 2005; 204: 55–73
- Toh M. L., Miossec P. The role of T cells in rheumatoid arthritis: new subsets and new targets. Curr Opin Rheumatol 2007; 19: 284–8
- Zhang J. Yin and yang interplay of IFN‐gamma in inflammation and autoimmune disease. J Clin Invest 2007; 117: 871–3
- Pahan K., Sheikh F. G., Namboodiri A. M., Singh I. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest 1997; 100: 2671–9
- Youssef S., Stuve O., Patarroyo J. C., Ruiz P. J., Radosevich J. L., Hur E. M., et al. The HMG‐CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 2002; 420: 78–84
- Weitz‐Schmidt G., Welzenbach K., Brinkmann V., Kamata T., Kallen J., Bruns C., et al. Statins selectively inhibit leukocyte function antigen‐1 by binding to a novel regulatory integrin site. Nat Med 2001; 7: 687–92
- Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
- van der Heijde D. M., van't Hof M. A., van Riel P. L., Theunisse L. A., Lubberts E. W., van Leeuwen M. A., et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990; 49: 916–20
- Blaschke S., Middel P., Dorner B. G., Blaschke V., Hummel K. M., Kroczek R. A., et al. Expression of activation‐induced, T cell‐derived, and chemokine‐related cytokine/lymphotactin and its functional role in rheumatoid arthritis. Arthritis Rheum 2003; 48: 1858–72
- Berner B., Akca D., Jung T., Muller G. A., Reuss‐Borst M. A. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. J Rheumatol 2000; 27: 1128–35
- Bessler H., Salman H., Bergman M., Straussberg R., Djaldetti M. In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells. Clin Immunol 2005; 117: 73–7
- Yokota K., Miyazaki T., Hirano M., Akiyama Y., Mimura T. Simvastatin inhibits production of interleukin‐6 (IL‐6) and IL‐8 and cell proliferation induced by tumor necrosis factor‐alpha in fibroblast‐like synoviocytes from patients with rheumatoid arthritis. J Rheumatol 2006; 33: 463–71
- Leung B. P., Sattar N., Crilly A., Prach M., McCarey D. W., Payne H., et al. A novel anti‐inflammatory role for simvastatin in inflammatory arthritis. J Immunol 2003; 170: 1524–30
- Kanda H., Yokota K., Kohno C., Sawada T., Sato K., Yamaguchi M., et al. Effects of low‐dosage simvastatin on rheumatoid arthritis through reduction of Th1/Th2 and CD4/CD8 ratios. Mod Rheumatol 2007; 17: 364–8
- McCarey D. W., McInnes I. B., Madhok R., Hampson R., Scherbakov O., Ford I., et al. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double‐blind, randomised placebo‐controlled trial. Lancet 2004; 363: 2015–21